![](/img/cover-not-exists.png)
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)
Thiel, A., Schetelig, J., Ponisch, W., Schafer-Eckart, K., Aulitzky, W., Peter, N., Schulze, A., Maschmeyer, G., Neugebauer, S., Herbst, R., Hanel, A., Morgner, A., Kroschinsky, F., Bornhauser, M., LaLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv205
Date:
April, 2015
File:
PDF, 668 KB
english, 2015